Late-onset male hypogonadism: Clinical and laboratory evaluation

Journal of Clinical Pathology

Volumn 64, Issue 6, 2011, Pages 459-465

  Ho, Clement K M ^a   Beckett, Geoffrey J ^b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTICONVULSIVE AGENT; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANOREXIA NERVOSA; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEPRESSION; DIABETES MELLITUS; ERECTILE DYSFUNCTION; FATIGUE; GYNECOMASTIA; HOT FLUSH; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHYROIDISM; INFERTILITY; INSULIN RESISTANCE; LATE ONSET MALE HYPOGONADISM; LIBIDO DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; SWEATING; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE METABOLISM;

AGE OF ONSET; AGING; ANDROGENS; HUMANS; HYPOGONADISM; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 79956302287     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.076968     Document Type: Review

References (68)

1. Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008;159:507-14.
2. Dhatariya K, Nagi D, Jones T. ABCD position statement on the management of hypogonadal males with type 2 diabetes. Practical Diabetes Int 2010;27:409-12.
3. Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging 2008;3:25-44. (Pubitemid 351559801)
4. Stanworth RD, Jones TH. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res 2009;37:74-90.
5. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-59.
6. Tait JF, Tait SA. The effect of plasma protein binding on the metabolism of steroid hormones. J Endocrinol 1991;131:339-57.
7. Ekins R. The free hormone hypothesis and measurement of free hormones. Clin Chem 1992;38:1289-93.
8. Mendel CM. The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl 1992;13:107-16.
9. Penning TM. New frontiers in androgen biosynthesis and metabolism. Curr Opin Endocrinol Diabetes Obes 2010;17:233-9.
10. Nuti R, Martini G, Merlotti D, et al. Bone metabolism in men: role of aromatase activity. J Endocrinol Invest 2007;30:18-23.
11. Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005;122:751-62. (Pubitemid 41242639)
12. Willnow TE, Nykjaer A. Cellular uptake of steroid carrier proteinsemechanisms and implications. Mol Cell Endocrinol 2010;316:93-102.
13. Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996;81:1821-6. (Pubitemid 26152470)
14. Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;147:750-4. (Pubitemid 28183274)
15. Atlantis E, Martin SA, Haren MT, et al. Demographic, physical and lifestyle factors associated with androgen status: the Florey Adelaide Male Ageing Study (FAMAS). Clin Endocrinol (Oxf) 2009;71:261-72.
16. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31. (Pubitemid 32207487)
17. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98. (Pubitemid 34158223)
18. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-76. (Pubitemid 41428540)
19. Morley JE, Kaiser FE, Perry HM 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46:410-13. (Pubitemid 27172090)
20. Pincus SM, Veldhuis JD, Mulligan T, et al. Effects of age on the irregularity of LH and FSH serum concentrations in women and men. Am J Physiol 1997;273: E989-95.
21. Mulligan T, Iranmanesh A, Kerzner R, et al. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis. Eur J Endocrinol 1999;141:257-66. (Pubitemid 29465931)
22. Mulligan T, Iranmanesh A, Veldhuis JD. Pulsatile iv infusion of recombinant human LH in leuprolide-suppressed men unmasks impoverished Leydig-cell secretory responsiveness to midphysiological LH drive in the aging male. J Clin Endocrinol Metab 2001;86:5547-53. (Pubitemid 33070287)
23. Greenspan SL, Klibanski A, Rowe JW, et al. Age alters pulsatile prolactin release: influence of dopaminergic inhibition. Am J Physiol 1990;258:E799-804.
24. Ono K, Haji M, Nawata H, et al. Age-related changes in glucocorticoid and androgen receptors of cultured human pubic skin fibroblasts. Gerontology 1988;34:128-33.
25. Diver MJ, Imtiaz KE, Ahmad AM, et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003;58:710-17. (Pubitemid 36702730)
26. Wylie K, Rees M, Hackett G, et al. Androgens, health and sexuality in women and men. Maturitus 2010;67:275-89.
27. Diver MJ. Laboratory measurement of testosterone. Front Horm Res 2009;37:21-31.
28. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74-86.
29. Swerdloff RS, Wang C. Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clin Chem 2008;54:458-60. (Pubitemid 351348150)
30. Wheeler MJ, Nanjee MN. A steady-state gel filtration method on micro-columns for the measurement of percentage free testosterone in serum. Ann Clin Biochem 1985;22:185-9. (Pubitemid 15115410)
31. Ly LP, Handelsman DJ. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 2005;152:471-8. (Pubitemid 40439501)
32. Goncharov N, Katsya G, Dobracheva A, et al. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status. Aging Male 2006;9:111-22. (Pubitemid 44266883)
33. Matsui F, Koh E, Yamamoto K, et al. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for simultaneous measurement of salivary testosterone and cortisol in healthy men for utilization in the diagnosis of late-onset hypogonadism in males. Endocr J 2009;56:1083-93.
34. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free estosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72. (Pubitemid 30645223)
35. Rosner W. An extraordinarily inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab 2001;86:2903. (Pubitemid 32545760)
36. Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004;89:525-33. (Pubitemid 38269853)
37. Carter GD, Holland SM, Alaghband-Zadeh J, et al. Investigation of hirsutism: testosterone is not enough. Ann Clin Biochem 1983;20:262-3. (Pubitemid 14244990)
38. Blight LF, Judd SJ, White GH. Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism. Ann Clin Biochem 1989;26:311-16. (Pubitemid 19185698)
39. Kapoor P, Luttrell BM, Williams D. The free androgen index is not valid for adult males. J Steroid Biochem Mol Biol 1993;45:325-6. (Pubitemid 23166567)
40. Vermeulen A. Reflections concerning biochemical parameters of androgenicity. Aging Male 2004;7:280-9. (Pubitemid 40070007)
41. Ho CK, Stoddart M, Walton M, et al. Calculated free testosterone in men: comparison of four equations and with free androgen index. Ann Clin Biochem 2006;43:389-97. (Pubitemid 44526539)
42. Sodergard R, Backstrom T, Shanbhag V, et al. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10. (Pubitemid 13228095)
43. Nanjee MN, Wheeler MJ. Plasma free testosterone-is an index sufficient? Ann Clin Biochem 1985;22:387-90.
44. Sartorius G, Ly LP, Sikaris K, et al. Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem 2009;46:137-43.
45. de Ronde W, van der Schouw YT, Pols HA, et al. Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clin Chem 2006;52:1777-84. (Pubitemid 44330714)
46. Emadi-Konjin P, Bain J, Bromberg IL. Evaluation of an algorithm for calculation of serum 'bioavailable' testosterone (BAT). Clin Biochem 2003;36:591-6.
47. Morris PD, Malkin CJ, Channer KS, et al. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. Eur J Endocrinol 2004;151:241-9. (Pubitemid 39207020)
48. Giton F, Fiet J, Guechot J, et al. Serum bioavailable testosterone: assayed or calculated? Clin Chem 2006;52:474-81.
49. Travison TG, Morley JE, Araujo AB, et al. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006;91:2509-13. (Pubitemid 44024610)
50. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123-35.
51. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239-42.
52. Heinemann LA, Saad F, Heinemann K, et al. Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging Male 2004;7:211-18.
53. Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010;95:1810-18.
54. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-43. (Pubitemid 44833407)
55. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007;92:4241-7. (Pubitemid 350074738)
56. Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004;89:5920-6. (Pubitemid 39628393)
57. Vermeulen A. Androgen replacement therapy in the aging male - a critical evaluation. J Clin Endocrinol Metab 2001;86:2380-90. (Pubitemid 32545680)
58. Glass AR, Swerdloff RS, Bray GA, et al. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 1977;45:1211-19. (Pubitemid 8253447)
59. Kley HK, Deselaers T, Peerenboom H. Evidence for hypogonadism in massively obese males due to decreased free testosterone. Horm Metab Res 1981;13:639-41. (Pubitemid 12237568)
60. Winters SJ, Kelley DE, Goodpaster B. The analog free testosterone assay: are the results in men clinically useful? Clin Chem 1998;44:2178-82.
61. Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril 2006;85:1319-40.
62. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990;132:895-901. (Pubitemid 20363668)
63. Chang TC, Tung CC, Hsiao YL. Hormonal changes in elderly men with non-insulin-dependent diabetes mellitus and the hormonal relationships to abdominal adiposity. Gerontology 1994;40:260-7.
64. Defay R, Papoz L, Barny S, et al. Hormonal status and NIDDM in the European and Melanesian populations of New Caledonia: a case-control study. The CALedonia DIAbetes Mellitus (CALDIA) Study Group. Int J Obes Relat Metab Disord 1998;22:927-34. (Pubitemid 28395962)
65. Corona G, Monami M, Rastrelli G, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl. Published Online First: 24 October 2010. doi:10.1111/j.1365-2605.2010.01117.x.
66. Fernandez-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95:2560-75.
67. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363:109-22.
68. Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010;95:4542-8.